Cross Staff Investments’s Elevance Health ELV Stock Holding History

Cross Staff Investments’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-976	Closed	-$460K	–	122
2023 Q4	$460K	Hold	976	–	–	0.41%	66
2023 Q3	$425K	Hold	976	–	–	0.42%	69
2023 Q2	$434K	Hold	976	–	–	0.4%	71
2023 Q1	$449K	Hold	976	–	–	0.44%	69
2022 Q4	$501K	Hold	976	–	–	0.53%	61
2022 Q3	$443K	Hold	976	–	–	0.5%	62
2022 Q2	$471K	Hold	976	–	–	0.52%	62
2022 Q1	$479K	Sell	976 -30	-3%	-$13.7K	0.44%	66
2021 Q4	$466K	Buy	+1,006	New	+$423K	0.42%	76

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cross Staff Investments's ELV Position: Q1 2024 in Review

Cross Staff Investments sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 976 shares — an estimated $460K sold.

Cross Staff Investments first reported a position in ELV in Q4 2021 and held it in 9 quarters. The position peaked at $501K in Q4 2022. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

Cross Staff Investments reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
Cross Staff Investments sold 976 Elevance Health shares in Q1 2024, an estimated $460K.
Cross Staff Investments first reported a position in Elevance Health in Q4 2021 and held it in 9 quarters.
Cross Staff Investments's Elevance Health position peaked at $501K in Q4 2022.
1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Cross Staff Investments's 13F filing for Q1 2024, filed 1 May 2024.